Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Sweden
  • Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Romania
  • Study Comparing Orforglipron and Dapagliflozin for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Metformin

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • A study testing ALN-4324 for safety and effectiveness in overweight to obese patients with type 2 diabetes

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Bulgaria Croatia Czechia Denmark Finland Germany +9
  • A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

    Not recruiting

    2 1 1
    Investigated diseases:
    France Greece Hungary Poland Slovakia Spain
  • A study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes not well controlled by diet and exercise

    Not recruiting

    3 1
    Investigated drugs:
    Hungary Italy Poland
  • A study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes taking basal insulin with or without metformin

    Not recruiting

    3 1 1
    Slovakia
  • Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +8
  • A study comparing weekly insulin icodec and semaglutide with daily insulin degludec and insulin aspart in people with type 2 diabetes not well controlled on premixed insulin

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Poland